Published in Infect Immun on October 01, 1999
Caspase-1-mediated activation of interleukin-1beta (IL-1beta) and IL-18 contributes to innate immune defenses against Salmonella enterica serovar Typhimurium infection. Infect Immun (2006) 2.35
Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun (2000) 1.21
Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun (2002) 0.97
Th1 and Th1-inducing cytokines in Salmonella infection. Clin Exp Immunol (2003) 0.93
A potential role for interleukin-18 in inhibition of the development of Cryptosporidium parvum. Clin Exp Immunol (2006) 0.90
[Not Available]. Open Microbiol J (2009) 0.75
Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature (1995) 10.89
Recombinant interleukin 12 cures mice infected with Leishmania major. J Exp Med (1993) 5.75
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med (1993) 5.71
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38
IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol (1999) 3.81
The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology (1995) 3.45
Measurement of invasion by gentamicin resistance. Methods Enzymol (1994) 3.38
IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J Immunol (1995) 3.29
Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med (1994) 3.02
Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect Immun (1992) 2.95
Salmonella as an intracellular parasite. Mol Microbiol (1989) 2.67
Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. Proc Natl Acad Sci U S A (1999) 2.57
Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells. J Exp Med (1998) 2.40
Induction of interferon-gamma production in Th1 CD4+ T cells: evidence for two distinct pathways for promoter activation. Eur J Immunol (1999) 2.14
Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun (1999) 2.14
Interferon-gamma: biology and role in pathogenesis. Adv Immunol (1996) 2.08
Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun (1998) 1.95
The role of IFN-gamma in murine Salmonella typhimurium infection. Microb Pathog (1990) 1.84
Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur J Immunol (1998) 1.77
Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J Exp Med (1995) 1.74
Salmonella typhimurium induces IFN-gamma production in murine splenocytes. Role of natural killer cells and macrophages. J Immunol (1993) 1.73
Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun (1997) 1.71
Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of gamma interferon and macrophage activation. Infect Immun (1998) 1.69
Effect of interleukin 12 neutralization on host resistance and gamma interferon production in mouse typhoid. Infect Immun (1996) 1.66
Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun (1996) 1.60
IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol (1997) 1.55
Aromatic-dependent Salmonella dublin as a parenteral modified live vaccine for calves. Am J Vet Res (1984) 1.54
A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice. J Immunol (1998) 1.26
In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat-labile enterotoxin. Infect Immun (1995) 1.24
Limited role of CD28-mediated signals in T helper subset differentiation. J Exp Med (1996) 1.21
CD40 ligand/CD40 stimulation regulates the production of IFN-gamma from human peripheral blood mononuclear cells in an IL-12- and/or CD28-dependent manner. J Immunol (1998) 1.20
Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12. J Immunol (1995) 1.18
Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect Immun (1996) 1.05
Thapsigargin and cyclopiazonic acid initiate rapid and dramatic increases of IL-6 mRNA expression and IL-6 secretion in murine peritoneal macrophages. J Immunol (1995) 1.04
Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages. Infect Immun (1997) 1.02
Regulation of human IL-18 mRNA expression. Clin Immunol (1999) 0.98
Lymphokine mRNA expression by transplantable murine B lymphocytic malignancies. Tumor-derived IL-10 as a possible mechanism for modulating the anti-tumor response. J Immunol (1995) 0.93
Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. Exp Parasitol (1996) 0.93
Differential capacities of CD4+, CD8+, and CD4-CD8- T cell subsets to express IL-18 receptor and produce IFN-gamma in response to IL-18. J Immunol (1998) 0.92
LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells. J Immunol (1998) 0.90
Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion. Pept Res (1992) 0.86
T helper subset differentiation in the absence of invariant chain. J Exp Med (1997) 0.85
Limitations for purification of murine interleukin-18 when expressed as a fusion protein containing the FLAG peptide. Biotechniques (1998) 0.77
Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci U S A (1985) 1.75
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Endogenous and exogenous interleukin-12 augment the protective immune response in mice orally challenged with Salmonella dublin. Infect Immun (1996) 1.60
Salmonella efficiently enter and survive within cultured CD11c+ dendritic cells initiating cytokine expression. Eur J Immunol (1999) 1.31
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J Rheumatol (1992) 1.29
Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. Biochem Biophys Res Commun (1985) 1.27
Substance P-induced IL-12 production by murine macrophages. J Immunol (1997) 1.26
Binding of peptides that are specified by complementary RNAs. Biochem J (1986) 1.16
Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc Natl Acad Sci U S A (1986) 1.15
Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. Immunology (1990) 1.12
Substance P activates NF-kappaB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J Neuroimmunol (2000) 1.11
Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp. Infect Immun (1996) 1.05
Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc Natl Acad Sci U S A (1988) 1.04
Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, spantide II. J Immunol (1996) 1.03
Infection of intestinal epithelial cells and development of systemic disease following gastric instillation of murine gammaherpesvirus-68. J Gen Virol (2000) 1.02
The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun (1986) 1.02
An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol (1986) 1.00
Molecular characterization of a corticotropin (ACTH) receptor. Mol Cell Endocrinol (1986) 0.98
IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol (2000) 0.98
Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J (1988) 0.96
Differential expression of functional adrenocorticotropic hormone receptors by subpopulations of lymphocytes. J Immunol (1989) 0.95
Involvement of mitogen-activated protein kinase pathways in Staphylococcus aureus invasion of normal osteoblasts. Infect Immun (2001) 0.93
Neuroendocrine peptide hormones and their receptors in the immune system. Production, processing and action. J Neuroimmunol (1985) 0.93
Cytokine involvement in immunomodulatory activity affected by Candida albicans mannan. Infect Immun (1998) 0.93
Dormant microbes in interstitial cystitis. J Urol (1995) 0.92
Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory. J Immunol (1987) 0.92
Differential kinetics for induction of interleukin-6 mRNA expression in murine peritoneal macrophages: evidence for calcium-dependent and independent-signalling pathways. J Cell Physiol (1998) 0.90
Hormone and neuropeptide receptors on mononuclear leukocytes. Prog Allergy (1988) 0.90
Extracellular uridine nucleotides initiate cytokine production by murine dendritic cells. Cell Immunol (1999) 0.90
Limited IL-6 production following infection with murine gammaherpesvirus 68. Arch Virol (2006) 0.89
Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity (1994) 0.88
Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol (2001) 0.88
Substance P diminishes lipopolysaccharide and interferon-gamma-induced TGF-beta 1 production by cultured murine macrophages. Cell Immunol (1998) 0.87
CD40-CD40 ligand interactions augment survival of normal mice, but not CD40 ligand knockout mice, challenged orally with Salmonella dublin. Infect Immun (1999) 0.86
Staphylococcus aureus and Salmonella enterica serovar Dublin induce tumor necrosis factor-related apoptosis-inducing ligand expression by normal mouse and human osteoblasts. Infect Immun (2001) 0.86
Anti-peptide antibodies recognize anti-substance P antibodies in an idiotypic fashion. Pept Res (1992) 0.86
Murine gammaherpesvirus-68-induced interleukin-10 increases viral burden, but limits virus-induced splenomegaly and leukocytosis. Immunology (2001) 0.86
Antipeptide antibodies that recognize a lymphocyte substance P receptor. J Immunol (1989) 0.85
Monoclonal antibody against a peptide specified by [Met]-enkephalin complementary RNA recognizes the delta-class opioid receptor. Immunol Lett (1989) 0.84
The cytokine-like action of substance P upon B cell differentiation. Reg Immunol (1992) 0.84
Immunoaffinity-purified opiate receptor specifically binds the delta-class opiate receptor ligand, cis-(+)-3-methylfentanylisothiocyanate, SUPERFIT. FEBS Lett (1987) 0.83
Substance P receptor mediated macrophage responses. Adv Exp Med Biol (2001) 0.83
Isolation, purification, and partial characterization of suppressin, a novel inhibitor of cell proliferation. J Biol Chem (1990) 0.82
Substance P dependence of endosomal fusion during bladder inflammation. Am J Physiol Renal Physiol (2000) 0.82
Substance P acts directly upon cloned B lymphoma cells to enhance IgA and IgM production. J Immunol (1991) 0.82
Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res (1999) 0.82
Ligand receptor characteristics of peptides encoded by complementary nucleic acids: implications for a molecular recognition code. Recent Prog Horm Res (1988) 0.81
Use of peptides encoded by complementary RNA for generating anti-idiotypic antibodies of predefined specificity. Methods Enzymol (1989) 0.81
High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas. Virology (1999) 0.81
Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblasts. Clin Immunol Immunopathol (1992) 0.80
Neuroimmune modulation of lymphocyte function--I. Substance P enhances immunoglobulin synthesis in lipopolysaccharide activated murine splenic B cell cultures. Int Immunol (1991) 0.80
Nitric oxide mediates immune dysfunction in the spontaneously hypertensive rat. Hypertension (1993) 0.80
Spontaneously hypertensive rat: lymphoid depression is age dependent and mediated via a mononuclear cell subpopulation. Am J Physiol (1992) 0.79
Salmonella infection does not increase expression and activity of the high affinity IL-12 receptor. J Immunol (2000) 0.79
A monoclonal anti-peptide antibody recognizes the adrenocorticotropic receptor. Biochem Biophys Res Commun (1990) 0.79
Preparation and use of complementary peptides. Methods Enzymol (1989) 0.78
5'-3' and 3'-5' translation of the same RNA results in hydropathically similar peptides that are antigenically related. Immunol Invest (1991) 0.78
Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine. Infect Immun (1996) 0.78
Limitations for purification of murine interleukin-18 when expressed as a fusion protein containing the FLAG peptide. Biotechniques (1998) 0.77
The production of antibodies which recognize opiate receptors on murine leukocytes. Life Sci (1988) 0.77
Characterization of antisera to the naloxone-insensitive receptor for beta-endorphin on U937 cells generated by using the complementary peptide strategy. J Pharmacol Exp Ther (1992) 0.76
The role of the Peyer's patch in carcinogenesis. I. The adsorption from the gut and retention of 3-methylcholanthrene by Peyer's patches. Carcinogenesis (1986) 0.76
Immune system dysfunction contributes to the aetiology of spontaneous hypertension. J Hypertens (1985) 0.76
Interleukin-2 does not attenuate hypertension in spontaneously hypertensive rats. Hypertension (1990) 0.76
[Not Available]. Open Microbiol J (2009) 0.75
Mechanisms that contribute to the development of lymphoid malignancies: roles for genetic alterations and cytokine production. Crit Rev Immunol (1996) 0.75
Anti-opioid receptor antibody recognition of a binding site on brain and leukocyte opioid receptors. Neuroendocrinology (1990) 0.75
Immunotherapy for food allergies. Past, present, future. Clin Rev Allergy Immunol (1999) 0.75
The role of the Peyer's patch in carcinogenesis. II. 3-Methylcholanthrene-induced lymphoid malignancies in rat Peyer's patches. Carcinogenesis (1986) 0.75
A monoclonal anti-peptide antibody mimics adrenocorticotropic hormone activity. Immunol Lett (1991) 0.75
Anti-IgD enhancement of primary antibody responses in rats. Cell Immunol (1981) 0.75
The regulation of antibody responses by mini-cytokines. Acta Neurol (Napoli) (1991) 0.75
EEG arousal sites of amphetamine and its psychotomimetic methoxy derivatives in rabbit brain. Biol Psychiatry (1971) 0.75
The enhancing effects of anti-IgD on B-lymphocyte functions in rats. Ann N Y Acad Sci (1982) 0.75
Role of intracellular Ca2+ stores in the regulation of electrogenic plasma membrane Ca2+ uptake in a B-lymphocytic cell line. J Cell Physiol (1994) 0.75
Changes in the DNA of lymphocytes from pristane treated rats. Agents Actions (1987) 0.75